(68)Ga-PSMA-PET/CT and Diffusion MRI Targeting for Cone-Beam CT-Guided Bone Biopsies of Castration-Resistant Prostate Cancer Patients

INTRODUCTION: Precision medicine expands the treatment options for metastatic castration-resistant prostate cancer (mCRPC) by targeting druggable genetic aberrations. Aberrations can be identified following molecular analysis of metastatic tissue. Bone metastases, commonly present in mCRPC, hinder p...

Descripción completa

Detalles Bibliográficos
Autores principales: van Steenbergen, T. R. F., Smits, M., Scheenen, T. W. J., van Oort, I. M., Nagarajah, J., Rovers, M. M., Mehra, N., Fütterer, J. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940314/
https://www.ncbi.nlm.nih.gov/pubmed/31444628
http://dx.doi.org/10.1007/s00270-019-02312-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940314/
https://www.ncbi.nlm.nih.gov/pubmed/31444628
http://dx.doi.org/10.1007/s00270-019-02312-8

Ejemplares similares